Blog > Articles by: Laura Cadden

Laura Cadden

 

Laura Cadden is a contributing editor to TodaysFinancialNews.com and host of TFN’s popular Smart Trading Action Alert. She gained hands-on-experience in financial publishing managing newsletters like Taipan and BreakAway Investor, as well as trading information services such as Volume Spike Alert and WaveStrength Options Weekly.

All articles by Laura Cadden:

Time to junk Javo Beverage (JAVO)
Posted January 28, 2009 in US Stocks and Markets

Drop Tesoro (TSO) before it’s too late
Posted January 28, 2009 in US Stocks and Markets

Geron Corporation (GERN) up 36% on news of FDA go-ahead
Posted January 24, 2009 in Featuring... & US Stocks and Markets

The year of Comcast (CMCSA)
Posted January 22, 2009 in Editor's Pic

Lithium: The one commodity with a profitable future
Posted January 20, 2009 in Investment Strategies

Four biotechs set to soar
Posted January 12, 2009 in Featuring... & Investment Strategies

Ally yourself with this video surveillance provider
Posted January 12, 2009 in Editor's Pic

Reap the gains on TFN’s stem cell stock recommendations!
Posted January 6, 2009 in Featuring... & US Stocks and Markets

Hold on to Isis Pharmaceuticals (ISIS)
Posted January 6, 2009 in US Stocks and Markets

Pick up shares of Service Corporation International (SCI)
Posted January 2, 2009 in Editor's Pic

The Best Ocean View in South America
Posted December 23, 2008 in Real Estate

Dump your shares of Take-Two Interactive (TTWO)
Posted December 18, 2008 in US Stocks and Markets

It’s time to buy Isis Pharmaceuticals (ISIS)
Posted December 17, 2008 in Editor's Pic

Argon ST (STST) may hold the key to future earnings in a war-weary world
Posted December 8, 2008 in Editor's Pic

Take gains on Penn National (PENN)
Posted December 8, 2008 in US Stocks and Markets

Drop these losers from your portfolio
Posted December 3, 2008 in Investment Strategies

Rest easy with Vanda Pharmaceuticals Inc. (VNDA)
Posted December 2, 2008 in Editor's Pic

The 3 Hottest Stem Cell Stocks Under $5
Posted November 26, 2008 in Featuring... & US Stocks and Markets

A day in the sun for two stem cell researchers: StemCells Inc. (STEM) and Brainstorm Cell Therapeutics (BCLI)
Posted November 10, 2008 in Investment Strategies

New administration could mean advances — and profits — for U.S. stem cell biotech companies
Posted November 5, 2008 in Investment Strategies & US Stocks and Markets